Immediate Impact

1 by Nobel laureates 74 standout
Sub-graph 1 of 22

Citing Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes
2023 Standout
1 intermediate paper

Works of Stephen E. McRae being referenced

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors
2005

Author Peers

Author Last Decade Papers Cites
Stephen E. McRae 191 109 273 275 217 16 590
Thierry Debaere 87 215 396 358 227 16 674
D. Ravizza 114 292 329 292 112 33 610
M E Clouse 249 332 173 258 117 17 659
Elias Mallas 127 177 195 305 117 25 608
E. D. Staren 91 222 301 175 107 18 555
Kyung Cho 148 131 137 192 101 18 559
I W Choo 140 465 149 118 136 12 653
PC Freeny 223 315 163 97 46 20 581
J. L. G. Blaauwgeers 168 189 186 151 213 31 637
Saya Igarashi 117 318 196 224 55 21 630

All Works

Loading papers...

Rankless by CCL
2026